COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20210620051639N2


Column Value
Trial registration number IRCT20210620051639N2
Full text link
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Dr. Jafar Salimian

Contact
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

jafar.salimian@gmail.com

Registration date
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

2021-10-11

Recruitment status
Last imported at : Dec. 11, 2021, 2:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Prevention

Inclusion criteria
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Healthy persons, 18-40 years old, Without uncontrolled underlying disease

Exclusion criteria
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

History of Covid-19 disease in the past month, positive coronavirus PCR test, uncontrolled underlying disease, T Important surgical history, receiving corona vaccine

Number of arms
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Bagheiat-allah University of Medical Sciences

Inclusion age min
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

40

Countries
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Healthy volunteers

Severity scale
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

N/A

Total sample size
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

300

primary outcome
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

IgG antibody against Receptor Binding Domain (RBD) protein Cellular immunity response against recombinant vaccine RBD protein Measurement of neutralizing Antibody based on virus neutralizing test (VNT)

Notes
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 2

Arms
Last imported at : Oct. 11, 2021, noon
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "80\u00b5g;3;days0-21-35;IM", "treatment_id": 1920, "treatment_name": "Noora", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]